Cite
APA Citation
Coward, J., Kichenadasse, G., Harnett, P., Moore, K., Barve, M., Berg, D., Garner, J., & Dizon, D. (n.d.). 1034PPhase I study of intraperitoneal TRX-E-002-1 in subjects with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer: Three-month follow-up results of the dose escalation phase. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100097081616.0x000021